Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Human Immune Response to the JYNNEOS Vaccine
Sponsor: Washington University School of Medicine
Summary
This study is designed to evaluate the magnitude and duration of the human adaptive immune response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine in the blood, lung mucosa, skin and bone marrow.
Official title: Evaluating the Durability of the Human Immune Response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-06-10
Completion Date
2026-12
Last Updated
2025-10-16
Healthy Volunteers
Yes
Conditions
Interventions
JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) suspension for subcutaneous injection
live, nonreplicating vaccine delivered according to the FDA approved package insert
Phlebotomy
Research blood draw
Research bronchoscopy
Outpatient research bronchoscopy with bronchoalveolar lavage and endobronchial biopsy performed with conscious sedation.
Skin punch biopsy
Skin punch biopsy performed with topical anesthesia.
Bone marrow aspiration
Bone marrow aspiration performed with local anesthesia.
Locations (1)
Washington University in Saint Louis School of Medicine Emergency Care and Research Core
St Louis, Missouri, United States